Orhun Akdoğan

21PUBLICATIONS
131CO-AUTHORS
Epidemiological modellingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 11, 2026
Wearable-derived postdischarge mobility as a digital biomarker for 90-day readmission and mortality in metastatic cancer.

|Aug 20, 2026
Topical Diclofenac for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Prospective Real-World Study.

|Jun 25, 2026
Real-World 30-Day Mortality After the Last Dose of Immune Checkpoint Inhibitors: A Multicenter Retrospective Cohort Study in Turkey.

|Mar 26, 2026
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).

Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu

|Mar 23, 2026
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study.

Osman Sütcüoğlu, Orhun Akdoğan, İlknur Deliktaş Onur

|Jan 12, 2026
Impact of vitamin D deficiency and inflammatory biomarkers on pathological response to neoadjuvant chemotherapy in breast cancer.

Kadriye Başkurt, Galip Can Uyar, Enes Yeşilbaş

Pageof 4

Frequent Collaborators

16 joint publications

Osman Sütcüoğlu

9 joint publications

Nuriye Özdemir

7 joint publications

Galip Can Uyar

6 joint publications

Ozan Yazıcı